Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 2
1960 1
1980 1
1996 1
1997 2
1998 1
2001 1
2002 3
2003 6
2004 1
2005 1
2006 3
2007 4
2008 1
2009 8
2010 5
2011 5
2012 5
2013 5
2014 4
2015 3
2016 9
2017 6
2018 7
2019 9
2020 19
2021 16
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

116 results
Results by year
Filters applied: . Clear all
Page 1
Burden-of-illness vaccine efficacy.
Callegaro A, Curran D, Matthews S. Callegaro A, et al. Pharm Stat. 2020 Sep;19(5):636-645. doi: 10.1002/pst.2020. Epub 2020 Mar 27. Pharm Stat. 2020. PMID: 32220002
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021.
Lai A, Bergna A, Menzo S, Zehender G, Caucci S, Ghisetti V, Rizzo F, Maggi F, Cerutti F, Giurato G, Weisz A, Turchi C, Bruzzone B, Ceccherini Silberstein F, Clementi N, Callegaro A, Sagradi F, Francisci D, Venanzi Rullo E, Vicenti I, Clementi M, Galli M; collaborative group SCIRE SARS-CoV-2 Italian Research Enterprise. Lai A, et al. Among authors: callegaro a. Virol J. 2021 Aug 14;18(1):168. doi: 10.1186/s12985-021-01638-5. Virol J. 2021. PMID: 34391446 Free PMC article.
Composition of the immunoglobulin G glycome associates with the severity of COVID-19.
Petrović T, Alves I, Bugada D, Pascual J, Vučković F, Skelin A, Gaifem J, Villar-Garcia J, Vicente MM, Fernandes Â, Dias AM, Kurolt IC, Markotić A, Primorac D, Soares A, Malheiro L, Trbojević-Akmačić I, Abreu M, Sarmento E Castro R, Bettinelli S, Callegaro A, Arosio M, Sangiorgio L, Lorini LF, Castells X, Horcajada JP, Pinho SS, Allegri M, Barrios C, Lauc G. Petrović T, et al. Among authors: callegaro a. Glycobiology. 2021 May 3;31(4):372-377. doi: 10.1093/glycob/cwaa102. Glycobiology. 2021. PMID: 33174592 Free PMC article.
Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules.
Costantini M, Callegaro A, Beran J, Berlaimont V, Galgani I. Costantini M, et al. Among authors: callegaro a. Hum Vaccin Immunother. 2020 Sep 1;16(9):2274-2279. doi: 10.1080/21645515.2019.1700712. Epub 2020 Jan 17. Hum Vaccin Immunother. 2020. PMID: 31951780 Free PMC article.
Response letter: "Predicted long-term antibody persistence for a tick-borne encephalitis vaccine: results from a modeling study beyond 10 years after a booster dose following different primary vaccination schedules".
Costantini M, Callegaro A, Beran J, Berlaimont V, Galgani I. Costantini M, et al. Among authors: callegaro a. Hum Vaccin Immunother. 2020 Sep 1;16(9):2282-2284. doi: 10.1080/21645515.2020.1798713. Epub 2020 Aug 18. Hum Vaccin Immunother. 2020. PMID: 32810427 Free PMC article. No abstract available.
116 results